3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Lung Diseases
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Digestive System Neoplasms
1
Colonic Neoplasms
1
Colonic Diseases
1
Carcinoma, Neuroendocrine
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Bronchial Neoplasms
1
Interventions
selinexor
1
pembrolizumab
1
pazopanib
1
Proton Therapy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Doxorubicin
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
repotrectinib
×
30 days
×
Clear all
No trials found.